Jazz Pharmaceuticals Presents Pre-Clinical Data for Pan-RAF Inhibitor JZP815, including Pharmacokinetic Properties and Efficacy in Multiple Solid Tumor Types Apr 8, 2022 01:00PM
Jazz Pharmaceuticals (JAZZ) Announces New Research Collaboration with Redx Pharma to Discover and Develop Two Targeted Cancer Therapies Sep 9, 2020 07:31AM
Jazz Pharmaceuticals Announces New Research Collaboration with Redx Pharma to Discover and Develop Two Targeted Cancer Therapies Sep 9, 2020 07:30AM